HLA-mismatched
Showing 1 - 25 of 1,147
Hematologic Malignancy, Stem Cell Transplant Complications Trial in Beijing (Beijing protocol)
Recruiting
- Hematologic Malignancy
- Stem Cell Transplant Complications
- Beijing protocol
-
Beijing, Beijing, ChinaDeparment of Hematology, Peking University People's Hospital
Jun 19, 2023
MDS, Secondary Acute Myeloid Leukemia Trial in Tampa (CD8 Depleted, Non-engrafting,HLA mismatched unrelated donor lymphocytes,
Recruiting
- Myelodysplastic Syndromes
- Secondary Acute Myeloid Leukemia
- CD8 Depleted, Non-engrafting,HLA mismatched unrelated donor lymphocytes
- Standard of Care Chemotherapy
-
Tampa, FloridaMoffitt Cancer Center
Sep 27, 2022
Kidney Transplant Rejection Trial (MDR-102, Immunosuppressive Agents)
Not yet recruiting
- Kidney Transplant Rejection
- MDR-102
- Immunosuppressive Agents
- (no location specified)
Apr 4, 2022
Acute Myeloid Leukemia, MDS Trial in Marseille (HLA-mismatched microtransplantation)
Recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- HLA-mismatched microtransplantation
-
Marseille, Bouches Du RhĂ´ne, FranceInstitut Paoli Calmettes
Oct 11, 2021
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Leukemia Trial in United States (drug, procedure, other, radiation)
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +10 more
- Busulfan
- +10 more
-
Jacksonville, Florida
- +5 more
Aug 14, 2023
Hematologic Malignancies Trial in Baltimore (drug, radiation, procedure)
Recruiting
- Hematologic Malignancies
- Fludarabine
- +7 more
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Feb 14, 2022
Transplant-Related Hematologic Malignancy Trial in Atlanta (Sargramostim, Control Arm)
Recruiting
- Transplant-Related Hematologic Malignancy
- Sargramostim
- Control Arm
-
Atlanta, GeorgiaNorthside Hospital
Oct 19, 2022
Severe Sickle Cell Disease, Bone Marrow Failure Syndromes, Metabolic Disorders Trial in New Haven, Saint Louis (RIC regimen,
Recruiting
- Severe Sickle Cell Disease
- +5 more
- RIC regimen
- GVHD prophylaxis regimen
-
New Haven, Connecticut
- +1 more
Feb 4, 2022
Acute Lymphoid Leukemia (ALL), Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML) Trial in New York (radiation, drug,
Active, not recruiting
- Acute Lymphoid Leukemia (ALL)
- +5 more
- Hyperfractionated total body irradiation
- +9 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 21, 2022
Hematologic Malignancies Trial in La Jolla (Cyclophosphamide 50 mg/kg IV Days 3 and 4 post transplant)
Suspended
- Hematologic Malignancies
- Cyclophosphamide 50 mg/kg IV Days 3 and 4 post transplant
-
La Jolla, CaliforniaUCSD Medical Center
Jul 20, 2022
Myeloid Malignancies Trial in Italy (GvHD prophylaxis)
Recruiting
- Myeloid Malignancies
- GvHD prophylaxis
-
Alessandria, Italy
- +32 more
Nov 23, 2022
Severe Aplastic Anemia, Bone Marrow Failure Syndromes Trial in Baltimore, Milwaukee (procedure, drug, radiation)
Completed
- Severe Aplastic Anemia
- Bone Marrow Failure Syndromes
- Bone marrow transplant
- +7 more
-
Baltimore, Maryland
- +1 more
Feb 10, 2022
Acute Leukemia, MDS Trial in Chicago (device, drug, other)
Recruiting
- Acute Leukemia
- MDS
- Arm1
- Arm 1
-
Chicago, IllinoisUniversity of Illinois Cancer Center
Oct 13, 2022
Sickle Cell Disease, Hemoglobinopathies Trial in Nashville (drug, procedure, radiation)
Active, not recruiting
- Sickle Cell Disease
- Hemoglobinopathies
- Thymoglobulin
- +7 more
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Dec 20, 2021
Ovarian Cancer Recurrent Trial in Beijing (microtransplantation, HLA-mismatched donor peripheral stem cell infusion)
Recruiting
- Ovarian Cancer Recurrent
- microtransplantation, HLA-mismatched donor peripheral stem cell infusion
-
Beijing, Beijing, ChinaThe third medical center of PLA General Hospital
Oct 26, 2021
Adult Acute Myeloid Leukemia Trial in Beijing (microtransplantation, HLA-mismatched donor peripheral stem cell infusion,
Recruiting
- Adult Acute Myeloid Leukemia
- microtransplantation, HLA-mismatched donor peripheral stem cell infusion
- +2 more
-
Beijing, Beijing, ChinaThe fifth medical center of PLA General Hospital
Feb 21, 2022
Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Atlanta (Fludarabine, Melphalan,
Completed
- Chronic Myelogenous Leukemia
- +9 more
- Fludarabine
- +3 more
-
Atlanta, GeorgiaNorthside Hospital
Apr 4, 2022
Hematologic Malignancy Trial in New York (melphalan, fludarabine, thiotepa)
Active, not recruiting
- Hematologic Malignancy
- melphalan
- +7 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 21, 2022
Acute Leukemia, MDS, T-lymphoblastic Lymphoma Trial (drug, radiation, procedure)
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +6 more
- Bone Marrow Hematopoeitic Cell Transplant (HCT)
- +9 more
- (no location specified)
Sep 27, 2021
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (drug,
Recruiting
- Acute Lymphoblastic Leukemia
- +7 more
- Busulfan
- +11 more
-
Duarte, California
- +26 more
Aug 11, 2022
Acute Myeloid Leukemia Trial in France (HLA-mismatched micro-transplantation after induction chemo)
Recruiting
- Acute Myeloid Leukemia
- HLA-mismatched micro-transplantation after induction chemotherapy
-
Clermont-Ferrand, France
- +6 more
Feb 7, 2022
Solid Tumors Trial in Beijing (microtransplantation, HLA-mismatched donor peripheral stem cell infusion)
Recruiting
- Solid Tumors
- microtransplantation, HLA-mismatched donor peripheral stem cell infusion
-
Beijing, Beijing, ChinaBeijing Fengtai You'anmen Hospital
Jun 16, 2021
Acute Leukemia, MDS, T-lymphoblastic Lymphoma Trial (drug, radiation, procedure)
Not yet recruiting
- Acute Leukemia
- +6 more
- Cyclophosphamide
- +8 more
- (no location specified)
Dec 8, 2021